A Survey of Survival Outcomes for Targeted Cancer Drugs Approved by the US Food and Drug Administration-Reference-Cited by-同舟云学术

A Survey of Survival Outcomes for Targeted Cancer Drugs Approved by the US Food and Drug Administration

Published:2021-03-08 Issue: Volume: Page:
ISSN:2168-4790
Container-title:Therapeutic Innovation & Regulatory Science
language:en
Short-container-title:Ther Innov Regul Sci

Author:

He Qian,Li Qiu,Lv Fanzhen,Kaitin Kenneth I.,Shao Liming

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1007/s43441-021-00264-1.pdf

Reference25 articles.

1. National Cancer Institute (NCI). Targeted therapy to treat cancer. https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies. Accessed 31 Dec 2019.

2. Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: treating cancer with specificity. Eur J Pharmacol. 2018;834:188–96.

3. National Cancer Institute (NCI). What targeted therapies have been approved for specific types of cancer? https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies. Accessed 31 Dec 2019.

4. Johnson JR, Williams G, Pazdur R. End points and United States Food and Drug Administration approval of oncology drugs. J Clin Oncol. 2003;21(7):1404–11.

5. Lesko LJ, Atkinson AJ. Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol. 2001;41:347–66.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survival Improvements in Advanced Hepatocellular Carcinoma with Sequential Therapy by Era;Cancers;2023-11-06

2. Efficacy of Off-Label Use of Anticancer Drugs in Oncology;Creative surgery and oncology;2023-06-30

3. Correlation of Anticancer Drug Prices with Outcomes of Overall Survival and Progression-Free Survival in Clinical Trials in Japan;Current Oncology;2023-02-01

4. Immunotherapy for brain metastases and primary brain tumors;European Journal of Cancer;2023-01

5. Correlation between clinical trial endpoints of marketed cancer drugs and reimbursement decisions in China;Frontiers in Public Health;2022-11-24